PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Use biologic agents to induce remission in patients with moderately severe Crohn's disease

New American Gastroenterological Association guidelines provide guidance on most effective treatment pathway

2013-12-17
(Press-News.org) Contact information: Aimee Frank
media@gastro.org
301-941-2620
American Gastroenterological Association
Use biologic agents to induce remission in patients with moderately severe Crohn's disease New American Gastroenterological Association guidelines provide guidance on most effective treatment pathway Bethesda, MD (Dec. 16, 2013) —The anti-TNF-α biologic agents, such as infliximab or adalimumab, are recommended to induce remission in patients with moderately severe Crohn's disease , according to a new guideline from the American Gastroenterological Association (AGA). Additionally, the guidelines recommend against using thiopurines or methotrexate alone to induce remission in these patients. The new guideline1 and accompanying technical review2 have been published in Gastroenterology, the official journal of the AGA Institute. The AGA Clinical Decision Support Tool, based on the guideline, can be reviewed at http://gastro.org/crohnsdecisiontool.

"Crohn's disease is a lifelong, relapsing disorder that can damage the bowel and lead to multiple abdominal operations over time. Deciding which medications are the best is a common dilemma for gastroenterologists and the Crohn's patients we treat. The disease can be disabling, but the drugs to control the disease can be toxic too and they can be costly. Balancing the benefits and the risks of the drugs and determining which medicines are most likely to keep the patient healthy is critical," according to Jonathan P. Terdiman, MD, lead author of the guidelines, and Chief of the Gastroenterology Service at the University of California, San Francisco Medical Center. "The new AGA guideline and clinical decision support tool will ease the decision process by providing transparent and actionable recommendations."

Crohn's disease is a chronic inflammatory bowel disease that causes significant morbidity and represents a considerable burden to society. It is estimated that 300,000 to 500,000 Americans suffer from Crohn's disease, costing the health-care system between $2.5 and $4 billion per year.

These guidelines are the first to make medication recommendations based on methodology that includes review of risks and benefits, patient preferences, and the quality of clinical evidence.

For the induction of remission, the guidelines recommend: Using anti-TNF-α drugs to induce remission in patients with moderately severe Crohn's disease (strong recommendation, moderate-quality evidence). Using anti-TNF-α monotherapy over thiopurine monotherapy to induce remission in patients who have moderately severe Crohn's disease (strong recommendation, moderate-quality evidence). Using anti-TNF-α drugs in combination with thiopurines over thiopurine monotherapy to induce remission in patients who have moderately severe Crohn's disease (strong recommendation, high-quality evidence).

For maintenance of remission, the guidelines recommend: Using thiopurines over no immunomodulator therapy to maintain a steroid-induced remission in patients with Crohn's disease (strong recommendation, moderate-quality evidence). Using anti-TNF-α drugs over no anti-TNF-α drugs to maintain a steroid or anti-TNF-α drug-induced remission in patients with Crohn's disease (strong recommendation, high-quality evidence).

### Read the "American Gastroenterological Association Institute Guideline on the Use of Thiopurines, Methotrexate, and Anti–TNF-a Biologic Drugs for the Induction and Maintenance of Remission in Inflammatory Crohn's Disease" to review all of the treatment recommendations.

This guideline is AGA's first to practice AGA's new clinical guideline development process that employs the Grading of Recommendations Assessment, Development and Evaluation (GRADE) methodology. GRADE has been adopted by several national and international societies, including the AGA, and is becoming the common methodology for the streamlined and rigorous development of clear, transparent and actionable guidelines.

1 Terdiman J P et al. American Gastroenterological Association Institute Guideline on the Use of Thiopurines, Methotrexate, and Anti–TNF-a Biologic Drugs for the Induction and Maintenance of Remission in Inflammatory Crohn's Disease. Gastroenterology 2013;145:1459. 2 Dassopoulos T et al. American Gastroenterological Association Institute Technical Review on the Use of Thiopurines, Methotrexate, and Anti–TNF-a Biologic Drugs for the Induction and Maintenance of Remission in Inflammatory Crohn's Disease. Gastroenterology 2013;145:1464.

About the AGA Institute The American Gastroenterological Association is the trusted voice of the GI community. Founded in 1897, the AGA has grown to include 17,000 members from around the globe who are involved in all aspects of the science, practice and advancement of gastroenterology. The AGA Institute administers the practice, research and educational programs of the organization. http://www.gastro.org.

About Gastroenterology Gastroenterology, the official journal of the AGA Institute, is the most prominent scientific journal in the specialty and is in the top 1 percent of indexed medical journals internationally. The journal publishes clinical and basic science studies of all aspects of the digestive system, including the liver and pancreas, as well as nutrition. The journal is abstracted and indexed in Biological Abstracts, Current Awareness in Biological Sciences, Chemical Abstracts, Current Contents, Excerpta Medica, Index Medicus, Nutrition Abstracts and Science Citation Index. For more information, visit http://www.gastrojournal.org.

Like AGA and Gastroenterology on Facebook. Join AGA on LinkedIn. Follow us on Twitter @AmerGastroAssn. Check out our videos on YouTube.


ELSE PRESS RELEASES FROM THIS DATE:

Smoking changes our genes

2013-12-17
Smoking changes our genes The fact that smoking means a considerable health risk is nowadays commonly accepted. New research findings from Uppsala University and Uppsala Clinical Research Center show that smoking alters several genes that can be associated ...

AAOS approves AUC for non-arthroplasty treatment of osteoarthritis of the knee

2013-12-17
AAOS approves AUC for non-arthroplasty treatment of osteoarthritis of the knee New AUC offers clinical expertise across medical specialties to help optimize patient care ROSEMONT, Ill. – The American Academy of Orthopaedic Surgeons (AAOS) Board of Directors ...

Uranium (IV) found to be mobile in a natural wetland

2013-12-17
Uranium (IV) found to be mobile in a natural wetland EPFL researchers studying a natural wetland near a decommissioned uranium mine in Limousin, France, have shown that under certain circumstances the uranium present in the wetland could be more mobile ...

Carsey Institute: Students with a disability more likely to be restrained, secluded in school

2013-12-17
Carsey Institute: Students with a disability more likely to be restrained, secluded in school DURHAM, N.H. – The restraint and seclusion of students in U.S. public schools in response to student behavior problems are used much more frequently on students with ...

Duration of diabetes and advancing age independently predict diabetes complications, risk of death

2013-12-17
Duration of diabetes and advancing age independently predict diabetes complications, risk of death The duration of diabetes and advancing age independently predict diabetes severity and risk of death in older adults with type 2 diabetes according to a study by the ...

Hippocampal volume loss in depression reflects glial loss

2013-12-17
Hippocampal volume loss in depression reflects glial loss Reports new study in Biological Psychiatry Philadelphia, PA, December 17, 2013 – Depression has been associated with reduced volume of the hippocampus in magnetic resonance imaging studies in humans. A new study ...

Health R&D spending moves slowly upward, driven by industry, philanthropy and voluntary associations

2013-12-17
Health R&D spending moves slowly upward, driven by industry, philanthropy and voluntary associations Federal R&D funding remains 'woefully inadequate' to address health threats and global competitiveness ALEXANDRIA, Va.—December 17, 2013—After declining in ...

The economically valuable sweet-gum trees: Taxonomy and 9 new combinations

2013-12-17
The economically valuable sweet-gum trees: Taxonomy and 9 new combinations The sweet-gum family Altingiaceae is a small group of wind-pollinated trees that produce hard, woody fruits that contain numerous seeds. This widespread tree family has been puzzling botanists ...

Social network spying could lead to low returns

2013-12-17
Social network spying could lead to low returns Intrusive candidate-screening negatively affects reputation and performance, and may invite law suits Organizations looking to hire new staff should rethink their clandestine use of social networking websites, such as ...

Targeted synthesis of natural products with light

2013-12-17
Targeted synthesis of natural products with light Potential pathway for drug development using photoreactions This news release is available in German. For chemists, natural substances are compounds formed by organisms to fulfill the myriad ...

LAST 30 PRESS RELEASES:

KTU experts reveal why cultural heritage is important for community unity

More misfolded proteins than previously known may contribute to Alzheimer’s and dementia

“Too much going on”: Autistic adults overwhelmed by non-verbal social cues

What’s driving America’s deep freezes in a warming world?

A key role of brain protein in learning and memory is deciphered by scientists

Heart attacks don’t follow a Hollywood script

Erin M. Schuman wins 2026 Nakasone Award for discovery on neural synapse function and change during formation of memories

Global ocean analysis could replace costly in-situ sound speed profiles in seafloor positioning, study finds

Power in numbers: Small group professional coaching reduces rates of physician burnout by nearly 30%

Carbon capture, utilization, and storage: A comprehensive review of CCUS-EOR

New high-temperature stable dispersed particle gel for enhanced profile control in CCUS applications

State gun laws and firearm-related homicides and suicides

Use of tobacco and cannabis following state-level cannabis legalization

Long-term obesity and biological aging in young adults

Eindhoven University of Technology and JMIR Publications announce unlimited open access publishing agreement

Orphan nuclear receptors in metabolic dysfunction-associated steatotic liver disease development

A technological breakthrough for ultra-fast and greener AI

Pusan National University researchers identify key barriers hindering data-driven smart manufacturing adoption

Inking heterometallic nanosheets: A scalable breakthrough for coating, electronics, and electrocatalyst applications

Adults with autism show similar brain mapping of body parts as typically developing adults

Uncovering behavioral clues to childhood maltreatment

Premenstrual symptoms linked to increased risk of cardiovascular disease

Newly discovered remains of ancient river landscapes control ice flow in East Antarctica

Newly discovered interstellar object 'may be oldest comet ever seen'

Animal-inspired AI robot learns to navigate unfamiliar terrain

Underserved youth less likely to visit emergency department for concussion in Ontario, study finds

‘Molecular shield’ placed in the nose may soon treat common hay fever trigger

Beetles under climate stress lay larger male eggs: Wolbachia infection drives adaptive reproduction strategy in response to rising temperature and CO₂

Groundbreaking quantum study puts wave-particle duality to work

Weekly injection could be life changing for Parkinson’s patients

[Press-News.org] Use biologic agents to induce remission in patients with moderately severe Crohn's disease
New American Gastroenterological Association guidelines provide guidance on most effective treatment pathway